References
- Jensen JC. Clinical pharmacokinetics of terbinafine (Lamisil). Clin Exp Dermatol 1989; 14: 110–113
- Niwano Y, Matsui M, Tabuchi T, et al. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum. Arzneimittelforschung Drug Res 1997; 47: 1056–1060
- Nakashima T, Nozawa A, Ito T, et al. Development of a new medium useful for the recovery of dermatophytes from clinical specimens by minimizing the carryover effect of antifungal agents. Microbiol Immunol 2002; 46: 83–88
- Ishizeki C, Iwahara S, Watanabe T, , et al. Studies on the preservatives especially on the inhibitory activity of polysorbate 80 and lecithin. Eisei Shikensho Hokoku 1973; 91: 82–88 (in Japanese).
- Yamaguchi H. Antifungal drugs. Med J 1996; 32: 135–144. (in Japanese).
- Naka W, Hanyaku H, Tajima S, et al. Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994; 32: 31–35
- Nishikawa T, Naka W. Evaluation of antifungal effects of terbinafine and itraconazole using neutral red staining. BrJ Dermatol 1994; 43: 4–6
- Okeke CN, Tsuboi R, Kawai M, et al. Isolation of an intron-containing partial sequence of the gene encoding dermatophyte actin (ACT) and detection of a fragment of the transcript by reverse transcription-nested PCR as a means of assessing the viability of dermatophytes in skin scales. J Clin Microb 2001; 39: 101–106